T
Tenaya Therapeutics, Inc. (TNYA)
NMS – Real Time Price. Currency in USD
1.00
+0.00 (0.19%)
At close: May 12, 2026, 4:00 PM EDT
0.99
-0.01 (-0.85%)
After-hours: May 12, 2026, 7:59 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
1.00
+0.00 (0.19%)
At close: May 12, 2026, 4:00 PM EDT
0.99
-0.01 (-0.85%)
After-hours: May 12, 2026, 7:59 PM EDT
Tenaya Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. Its lead product candidate includes TN-201, a gene therapy for myosin binding protein C3-associated hypertrophic cardiomyopathy that is in Phase 1b/2 clinical trial; TN-401, a gene therapy for plakophilin 2-associated arrhythmogenic right ventricular cardiomyopathy, which is in Phase 1b/2 clinical trial; and TN-301, a small molecule histone deacetylase-6 for heart failure with preserved ejection fraction that is in phase 1 clinical trial. The company develops its products through gene addition, gene editing, gene silencing, and cellular regeneration. It has a research collaboration agreement with Alnylam Pharmaceuticals, Inc. to identify and validate novel gene targets for the potential treatment of cardiovascular disease. Tenaya Therapeutics, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.
| Name | Position |
|---|---|
| Dr. Benoit G. Bruneau Ph.D. | Scientific Founder |
| Dr. Bruce R. Conklin M.D. | Scientific Founder |
| Dr. Deepak Srivastava M.D. | Scientific Founder, Chairman of Scientific Advisory Board & Director |
| Dr. Eric N. Olson Ph.D. | Scientific Founder & Member of Scientific Advisory Board |
| Dr. Kee-Hong Kim Ph.D. | Chief Technology Officer |
| Dr. Saptarsi Haldar M.D. | Scientific Founder |
| Dr. Sheng Ding Ph.D. | Scientific Founder |
| Dr. Whittemore G. Tingley M.D., PH.D. | Chief Medical Officer |
| Mr. Faraz Ali M.B.A. | CEO, Interim Principal Financial Officer & Director |
| Mr. Tomohiro Higa M.B.A. | Senior Vice President of Finance & Interim Principal Accounting Officer |
| Date | Type | Document |
|---|---|---|
| 2026-05-06 | 10-Q | tnya-20260331.htm |
| 2026-04-16 | DEFA14A | tnya-a14a-2025.htm |
| 2026-03-11 | 8-K | tnya-20260311.htm |
| 2026-03-05 | 8-K | tnya-20260304.htm |
| 2026-02-03 | S-8 | tnya-20260202.htm |
| 2026-01-30 | 8-K | tnya-20260126.htm |
| 2026-01-02 | 8-K | tnya-20251231.htm |
| 2025-12-12 | 8-K | d67398d8k.htm |
| 2025-12-11 | 8-K | d68368d8k.htm |
| 2025-11-10 | 8-K | tnya-20251110.htm |